- Medical Devices
- Friday, 26 Mar 2021
Europe Region to Attract Manufacturers Attention in the Europe Biopharmaceutical Contract Manufacturing Market through 2027
According to The Insight Partners market research study of ‘Biopharmaceuticals Contract ManufacturingMarketto 2027 – Global Analysis and Forecasts by Product, and Service.’ The global biopharmaceuticals contract manufacturingmarket is expected to reach US$ 25,497.26Mn in 2027 from 13,727.13Mn in 2019. The market is estimated to grow with a CAGR of 8.2% from 2020-2027. The report provides trends prevailing in the global biopharmaceuticals contract manufacturing marketand the factors driving market along with those that act as hindrances.
The global biopharmaceuticals contract manufacturing market, based on the product, is segmented into biologics and biosimilars.The biologicssegment held the largest share of the market in 2019. Whereas, the biosimilar segment is estimated to register the highest CAGR in the market during the forecast period owing to increasing demand of biologics, increasing research activities in niche markets and growing biologics pipeline. Moreover, many big pharmaceutical companies prefer contract manufacturers to scale up their production and manage operating expenses.
The biopharmaceuticals contract manufacturing market is expected to grow, owing to the increasing outsourcing by pharmaceutical companies, growing biologics pipeline and growth in emerging markets. However, increasing competition among contract manufacturers is expected to restraint the growth of the market during the forecast years.
Leading companies operating in the biopharmaceuticals contract manufacturing marketare Lonza Group AG, Boehringer Ingelheim International GmbH, Inno Biologics Ventures Sdn Bhd,Thermo Fisher Scientific, AbbVie Inc., and WuXi Biologics, General Electric, Samsung Biologics, Merck KGaA, Ajinomoto Co., Inc. among others.
Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00010241/
Europe Biopharmaceutical Contract Manufacturing Market - Companies Mentioned
- Lonza Group AG
- Boehringer Ingelheim International GmbH
- Inno Biologics Ventures Sdn Bhd
- Thermo Fisher Scientific
- AbbVie Inc.
- WuXi Biologics
- General Electric
- Samsung Biologics
- Merck KGaA
- Ajinomoto Co., Inc
EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING – MARKET SEGMENTATION
Europe Biopharmaceutical Contract Manufacturing Market - By Product
Europe Biopharmaceutical Contract Manufacturing Market - By Service
- Development Process
- Final Dosage Operation
- Analytical and Quality Control
- Final Packaging
Europe Biopharmaceutical Contract Manufacturing Market - By Country
- Germany
- France
- UK
- Italy
- Spain
Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00010241/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Related Industry Updates
Operation Room Market Share, Size, Trends, Top Players and Forecast by 2026 | Steris, Getinge Ab, Barco, Merivaara, Stryker, GE Healthcare, Surgical Information Systems
Mar 15, 2021
North America Artificial Joints Market is Projected to Reach US$ 11,440.2 million by 2027
Dec 03, 2020
US and Europe Smart Hospital Beds Market is expected to reach US$ 859.45 million by 2028
Mar 27, 2023
Wearable Medical Devices Market with COVID-19 Impact and Recovery Analysis Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast 2025
Apr 28, 2021
Helical CT Scanner Market US$ 1,236.29 million by 2030
Feb 12, 2024
Asia Pacific Biopsy Devices Market is rising during 2019-2027 with Top Companies Like Medtronic, Fujifilm Corporation, Danaher
Dec 31, 2020
Europe Infertility Treatment Devices and Equipment Market is Estimated to Grow with a CAGR of 8.1% from 2020-2027
Nov 28, 2020
Follow us on
